Practice question

Answer the question and get instant feedback.

Easy"ACC Expert Consensus Decision Pathway (2022): Nonstatin Therapies for LDL-C Lowering"ASCVD"secondary prevention lipids"

A 54-year-old with ASCVD on maximally tolerated high-intensity statin has LDL-C 92 mg/dL. What is the next best step to reach guideline targets?

Practice more on iatroX

Educational content. Not a substitute for clinical judgement or local policy.